Prediction of occurrence and severity of CRS or ICANS by ROC curve analysis in pediatric and AYA patients treated with CD19-CAR T cells. ROC curve analysis displaying prediction of occurrence and severity of CRS (A-B) and ICANS (C-D) by EASIX (blue) and m-EASIX (red) scores at days –5, 0, and +3.